The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Open accessAbstract
AIM: To investigate the relationship between the gut-liver axis and nonalcoholic fatty liver disease (NAFLD), we performed a meta-analysis to evaluate the effects of probiotic therapy in NAFLD. METHODS: We searched PubMed, Medline, Embase, Web of Science, the Cochrane Library and Chinese Biomedicine Database for all relevant randomized controlled trials on probiotics in patients with NAFLD/nonalcoholic steatohepatitis (NASH). A statistical analysis was performed using RevMan 5.0 software. RESULTS: Four randomized trials involving 134 NAFLD/NASH patients were included. The results showed that probiotic therapy significantly decreased alanine aminotransferase (ALT), aspartate transaminase (AST), total-cholesterol (T-chol), high density lipoprotein (HDL), tumor necrosis factor (TNF)-α and homeostasis model assessment of insulin resistance (HOMA-IR) [ALT: weighted mean difference (WMD) -23.71, 95%CI: -33.46--13.95, P < 0.00001; AST: WMD -19.77, 95%CI: -32.55--7.00, P = 0.002; T-chol: WMD -0.28, 95%CI: -0.55--0.01, P = 0.04; HDL: WMD -0.09, 95%CI: -0.16-0.01, P = 0.03; TNF-α: WMD -0.32, 95%CI: -0.48--0.17, P < 0.0001; HOMA-IR: WMD -0.46, 95%CI: -0.73--0.19, P = 0.0008]. However, the use of probiotics was not associated with changes in body mass index (BMI), glucose (GLU) and low density lipoprotein (LDL) (BMI: WMD 0.05, 95%CI: -0.18-0.29, P = 0.64; GLU: WMD 0.05, 95%CI: -0.25-0.35, P = 0.76; LDL: WMD -0.38, 95%CI: -0.78-0.02, P = 0.06). CONCLUSION: Probiotic therapies can reduce liver aminotransferases, total-cholesterol, TNF-α and improve insulin resistance in NAFLD patients. Modulation of the gut microbiota represents a new treatment for NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent meta-analysis concluded that probiotics can reduce liver aminotransferases, total cholesterol, tumour necrosis factor α and improve insulin resistance in patients with NAFLD.56”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Correspondence - Tranexamic acid for traumatic brain injury
(2005) · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) · doi:10.1016/s0140-6736 · Cited by 11,894
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Research works printed but not linked: 2
- Salminen S. Uniqueness of probiotic strains. IDF Nutr News- letter 1996; 5: 16-18 13
- Hofacre CL, Mathis GF, Quiroz MA. Natural alternatives to prevent necrotic enteritis. Int Poult Prod 2005; 13: 7-9 60
Cited by
Sorted by citations
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., Lekic, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020395 · Cited by 551
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Khan, R. S., Bril, F., Cusi, K. J., & Newsome, P. N. (2018) · Hepatology · doi:10.1002/hep.30429 · Cited by 552
Gut microbiota and metabolic syndrome
Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534
Bifidobacteria and Their Health-Promoting Effects
Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B., & Margolles, A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0010-2016 · Cited by 490
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 427
Thirty Years of Lactobacillus rhamnosus GG
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 400
Probiotics in prevention and treatment of obesity: a critical view
Kobyliak, N. M., Conte, C., Cammarota, G., Haley, A. P., Štyriak, I., Gašpar, Ľ., Fusek, J., Rodrigo, L., & Kružliak, P. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0067-0 · Cited by 373
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
Kirpich, I. A., Marsano, L. S., & McClain, C. J. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.06.023 · Cited by 327
Stojsavljević, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18070 · Cited by 336
Koutnikova, H., Genser, B., Monteiro-Sepulveda, M., Faurie, J.-M., Rizkalla, S., Schrezenmeir, J., & Clément, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2017-017995 · Cited by 299
Vallianou, N. G., Christodoulatos, G. S., Karampela, Ι., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D. C., & Dalamaga, Μ. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 305
A concise review of non-alcoholic fatty liver disease
Than, N. N., & Newsome, P. N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.001 · Cited by 296
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
Luther, J., Garber, J. J., Khalili, H., Dave, M., Bale, S. S., Jindal, R., Motola, D. L., Luther, S., Bohr, S., Jeoung, S. W., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.001 · Cited by 286
Non-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease
Parekh, P. J., Balart, L. A., & Johnson, D. A. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.16 · Cited by 219
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
Paolella, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15518 · Cited by 222
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Perdomo, C. M., Frühbeck, G., & Escalada, J. (2019) · Nutrients · doi:10.3390/nu11030677 · Cited by 222
Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses
Rondanelli, M., Faliva, M. A., Perna, S., Giacosa, A., Peroni, G., & Castellazzi, A. M. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1345414 · Cited by 201
Zhang, Q., Wu, Y., & Fei, X. (2016) · Medicina · doi:10.1016/j.medici.2015.11.008 · Cited by 197
Clemente, M. G., Mandato, C., Poeta, M., & Vajro, P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8078 · Cited by 189
Sharpton, S. R., Maraj, B., Harding-Theobald, E. R., Vittinghoff, E., & Terrault, N. A. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz042 · Cited by 189
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
Hassan, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12082 · Cited by 192
Nor, M. H. M., Ayob, N., Mokhtar, N. M., Ali, R. A. R., Tan, G. C., Wong, Z., Shafiee, N. H., Wong, Y. P., Mustangin, M., & Nawawi, K. N. M. (2021) · Nutrients · doi:10.3390/nu13093192 · Cited by 179
Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 188
Gut microbiota and liver diseases
Minemura, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1691 · Cited by 178
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Bajaj, J. S., & Khoruts, A. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.017 · Cited by 172
Probiotics for people with hepatic encephalopathy
Dalal, R., McGee, R., Riordan, S. M., & Webster, A. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008716.pub3 · Cited by 175
O’Sullivan, A. M., Farver, M., & Smilowitz, J. T. (2015) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s29530 · Cited by 161
Han, S. H., Suk, K. T., Kim, D. J., Kim, M. Y., Baik, S. K., Kim, Y. D., Cheon, G. J., Choi, D. H., Ham, Y. L., Shin, D. H., et al. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000458 · Cited by 149
Loman, B. R., Hernández‐Saavedra, D., An, R., & Rector, R. S. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy031 · Cited by 147
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · Nutrients · doi:10.3390/nu11112642 · Cited by 152
Human microbiome and metabolic health: An overview of systematic reviews
Michels, N., Zouiouich, S., Vanderbauwhede, B., Vanacker, J., Ruiz, B. I. I., & Huybrechts, I. (2022) · Obesity Reviews · doi:10.1111/obr.13409 · Cited by 150
Kim, B., Park, K.-Y., Ji, Y., Park, S., Holzapfel, W. H., & Hyun, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.107 · Cited by 137
Kazemi, A., Soltani, S., Ghorabi, S., Keshtkar, A., Daneshzad, E., Nasri, F., & Mazloomi, S. M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.004 · Cited by 131
Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
Hernández‐Rodas, M. C., Valenzuela, R., & Videla, L. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025168 · Cited by 131
Virk, M. S., Virk, M. A., He, Y., Tufail, T., Gul, M., Qayum, A., Rehman, A., Rashid, A., Ekumah, J., Han, X., et al. (2024) · Nutrients · doi:10.3390/nu16040546 · Cited by 144
Lee, N. Y., Yoon, S. J., Han, D. H., Gupta, H., Youn, G. S., Shin, M. J., Ham, Y. L., Kwak, M. J., Kim, B., Yu, J. S., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1712984 · Cited by 127
The effect of probiotics on inflammatory biomarkers: A meta-analysis of randomized clinical trials
Milajerdi, A., Mousavi, S. M., Sadeghi, A., Salari-Moghaddam, A., Parohan, M., Larijani, B., & Esmaillzadeh, A. (2020) · European Journal of Nutrition · doi:10.1007/s00394-019-01931-8 · Cited by 123
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.073 · Cited by 123
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Machado, M. V., & Cortez‐Pinto, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040481 · Cited by 129
Wang, W., Xu, A.-L., Li, Z.-C., Li, Y., Xu, S.-F., Sang, H.-C., & Zhi, F. C. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0042 · Cited by 124
Zhang, Q., Wu, Y., & Fei, X. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1181156 · Cited by 124
Li, F., Ye, J., Shao, C., & Zhong, B. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01440-w · Cited by 118
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
Tsuei, J., Chau, T., Mills, D. A., & Wan, Y. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538743 · Cited by 119
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
Doulberis, M., Kotronis, G., Gialamprinou, D., Kountouras, J., & Katsinelos, P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.03.013 · Cited by 117
Barazzoni, R., Deutz, N. E. P., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., Cuerda, C., Delzenne, N., Leon Sanz, M., Ljungqvist, O., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.09.010 · Cited by 112
Wang, X., Shi, L., Wang, X., Feng, Y., & Wang, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.007 · Cited by 111
Drożdż, K., Nabrdalik, K., Hajzler, W., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2021) · Nutrients · doi:10.3390/nu14010103 · Cited by 115
Al-Muzafar, H. M., & Amin, K. A. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1540-z · Cited by 112
Kobyliak, N. M., Abenavoli, L., Falalyeyeva, T. M., Mykhalchyshyn, G., Boccuto, L., Kononenko, L., Kyriienko, D., Komisarenko, I., & Dynnyk, O. (2018) · Minerva Medica · doi:10.23736/s0026-4806.18.05845-7 · Cited by 111
Palma, R., Pronio, A., Romeo, M., Scognamiglio, F., Ventriglia, L., Ormando, V. M., Lamazza, A., Pontone, S., Federico, A., & Dallio, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133649 · Cited by 113
The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
Ferolla, S. M., Armiliato, G. N. D. A., Couto, C. A., & Ferrari, T. C. A. (2014) · Nutrients · doi:10.3390/nu6125583 · Cited by 104
Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic Properties
Druart, C., Alligier, M., Salazar, N., Neyrinck, A. M., & Delzenne, N. M. (2014) · Advances in Nutrition · doi:10.3945/an.114.005835 · Cited by 108
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Kelley, C. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14172 · Cited by 107
Liu, L., Li, P., Liu, Y., & Zhang, Y. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05699-z · Cited by 101
Askari, G., Asgharian, A., Esmailzade, A., Feizi, A., & Mohammadi, V. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.178533 · Cited by 102
Gao, X., Zhu, Y., Yang, W., Liu, G., & Wan, C. (2016) · Hepatology Research · doi:10.1111/hepr.12671 · Cited by 97
Jamilian, M., Amirani, E., & Asemi, Z. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.10.028 · Cited by 97
RetractedEo, H., Jeon, Y., Lee, M., & Lim, Y. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502830b · Cited by 99
Hadi, A., Mohammadi, H., Miraghajani, M. S., & Ghaedi, E. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1458021 · Cited by 94
Kanda, T., Goto, T., Hirotsu, Y., Masuzaki, R., Moriyama, M., & Omata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041525 · Cited by 97
Askari, G., Shoaei, T., Heidari‐Beni, M., Tehrani, H. G., Feizi, A., & Esmaillzadeh, A. (2015) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.153866 · Cited by 94
Endocrine causes of nonalcoholic fatty liver disease
Marino, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11053 · Cited by 93
Lau, L. H. S., & Wong, S. H. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_9 · Cited by 93
Nonalcoholic Fatty Liver Disease and the Gut Microbiome
Boursier, J., & Diehl, A. M. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.012 · Cited by 93
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Tu, T., Budzinska, M. A., Maczurek, A. E., Cheng, R., Bartolomeo, A. D., Warner, F. J., McCaughan, G. W., McLennan, S. V., & Shackel, N. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069422 · Cited by 90
Pang, J., Xu, W., Zhang, X., Wong, G. L., Chan, A. W. H., Chan, H., Tse, C., Shu, S. S., Choi, P. C., Chan, H. L., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14119 · Cited by 91
Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice
Kim, B., Kwon, J., Kim, M., Park, H., Ji, Y., Holzapfel, W. H., & Hyun, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0210120 · Cited by 92
Jayakumar, S., & Loomba, R. S. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 87
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Xiao, M.-W., Lin, S., Shen, Z., Luo, W., & Wang, X. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1484598 · Cited by 85
Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial
Dagan, S. S., Zelber‐Sagi, S., Zilberman-Schapira, G., Webb, M., Buch, A., Keidar, A., Raziel, A., Sakran, N., Goitein, D., Goldenberg, N. A., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.210 · Cited by 80
An update on the recent advances in antifibrotic therapy
Tacke, F., & Weiskirchen, R. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1530110 · Cited by 79
Galiero, R., Caturano, A., Vetrano, E., Cesaro, A., Rinaldi, L., Salvatore, T., Marfella, R., Sardu, C., Moscarella, E., Gragnano, F., et al. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2203082 · Cited by 86
A consumer’s guide for probiotics: 10 golden rules for a correct use
Toscano, M., Grandi, R. D., Pastorelli, L., Vecchi, M. L., & Drago, L. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.07.011 · Cited by 76
Prebiotics and probiotics in atopic dermatitis (Review)
Rusu, E., Enache, G., Cursaru, R., Alexescu, A., Radu, R., Onila, O., Cavallioti, T., Rusu, F., Posea, M., Jinga, M., et al. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7678 · Cited by 77
Pezzino, S., Sofia, M., Faletra, G., Mazzone, C., Litrico, G., Greca, G. L., & Latteri, S. (2022) · Biology · doi:10.3390/biology11111622 · Cited by 77
Lu, J., Shataer, D., Yan, H., Dong, X., Zhang, M., Qin, Y., Cui, J., & Wang, L. (2024) · Foods · doi:10.3390/foods13182992 · Cited by 77
Lambert, J. E., Parnell, J. A., Eksteen, B., Raman, M., Bomhof, M. R., Rioux, K. P., Madsen, K. L., & Reimer, R. A. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0400-5 · Cited by 73
Gut microbiota and non-alcoholic fatty liver disease
Gkolfakis, P., Dimitriadis, G., & Τriantafyllou, Κ. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60026-1 · Cited by 80
Chandan, R. C., Gandhi, A., & Shah, N. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805134-4.00001-8 · Cited by 70
Abhari, K., Saadati, S., Yari, Z., Hosseini, H., Hedayati, M., Abhari, S., Alavian, S. M., & Hekmatdoost, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.06.020 · Cited by 69
Exercise and diet in the management of nonalcoholic fatty liver disease
Mahady, S. E., & George, J. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.032 · Cited by 73
Gut Microbiota and Obesity in Adults and Children: The State of the Art
Petraroli, M., Castellone, E., Patianna, V. D., & Esposito, S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.657020 · Cited by 68
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Hossain, N., Kanwar, P., & Mohanty, S. R. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/7109270 · Cited by 70
Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis
Lavekar, A. S., Raje, D. V., & Lavekar, A. A. (2017) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1233 · Cited by 67
Pan, Y., Yang, Y., Wu, J., Zhou, H., & Yang, C. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03356-y · Cited by 81
Musazadeh, V., Roshanravan, N., Dehghan, P., & Ahrabi, S. S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.844242 · Cited by 69
Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders
Lim, S. K., Oh, T. J., & Koh, K. K. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.107 · Cited by 64
Zarezadeh, M., Musazadeh, V., Faghfouri, A. H., Roshanravan, N., & Dehghan, P. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2004578 · Cited by 61
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.003 · Cited by 70
Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease
de Oliveira, C. P. M. S., Sanches, P. D. L., de Abreu-Silva, E. O., & Marcadenti, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/4597246 · Cited by 64
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
Perumpail, B. J., Li, A. A., John, N., Sallam, S., Shah, N. D., Kwong, W., Cholankeril, G. T., Kim, D., & Ahmed, A. (2019) · Diseases · doi:10.3390/diseases7010027 · Cited by 60
Targeting Dysbiosis for the Treatment of Liver Disease
Anand, G. S., Zarrinpar, A., & Loomba, R. S. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571276 · Cited by 59
Starring role of toll-like receptor-4 activation in the gut-liver axis
Carotti, S. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.99 · Cited by 59
Cui, Y., Qi, S., Zhang, W., Mao, J., Tang, R., Wang, C., Liu, J., Luo, X., & Wang, H. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz088 · Cited by 58
Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies
Leylabadlo, H. E., Ghotaslou, R., Kafil, H. S., Feizabadi, M. M., Moaddab, S. Y., Farajnia, S., Sheykhsaran, E., Sanaie, S., Shanehbandi, D., & Baghi, H. B. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03746-1 · Cited by 56
Cheon, S. Y., & Song, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00836-0 · Cited by 58
Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12280 · Cited by 62
Metadata
- Authors
- Ma, Y.-Y.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2013
- Volume
- 19
- Issue
- 40
- Pages
- 6911
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC3812493
- OpenAlex
- W2151623669
- Cited by
- 352
- References
- 63
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 23 · 2023: 23 · 2022: 26 · 2021: 39 · 2020: 19 · 2019: 35 · 2018: 24 · 2017: 42 · 2016: 24 · 2015: 42 · 2014: 26 · 2013: 1
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, gut-liver axis, alanine aminotransferase, aspartate aminotransferase, insulin resistance, TNF-α, serum cholesterol, HDL cholesterol, LDL cholesterol, body mass index, glucose, liver enzymes, dyslipidemia, inflammation
- MeSH terms
- Fatty Liver, Humans, Insulin Resistance, Intestines, Liver, Chi-Square Distribution, Odds Ratio, Treatment Outcome, Probiotics, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
